Detalhe da pesquisa
1.
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.
Lancet
; 402(10405): 871-881, 2023 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37478883
2.
Pathologic Processing of Lung Cancer Resection Specimens After Neoadjuvant Therapy.
Mod Pathol
; 37(1): 100353, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844869
3.
Immune evasion in HPV- head and neck precancer-cancer transition is driven by an aneuploid switch involving chromosome 9p loss.
Proc Natl Acad Sci U S A
; 118(19)2021 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33952700
4.
Spatial PD-L1, immune-cell microenvironment, and genomic copy-number alteration patterns and drivers of invasive-disease transition in prospective oral precancer cohort.
Cancer
; 129(5): 714-727, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597662
5.
High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed.
Ann Surg
; 277(5): 721-726, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36052678
6.
Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma.
Mod Pathol
; 36(12): 100326, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678674
7.
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of Recurrence in Stage I Non-Small Cell Lung Cancer.
Mod Pathol
; 36(1): 100028, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788067
8.
Surgeons of the Future: A Novel Screening Tool for High-School Students.
J Surg Res
; 290: 61-70, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37209525
9.
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.
Nature
; 546(7659): 498-503, 2017 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28607485
10.
Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified.
Cancer
; 128(3): 509-518, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34661906
11.
Inhibition of the Phosphatidylinositol-3 Kinase Pathway Using Bimiralisib in Loss-of-Function NOTCH1-Mutant Head and Neck Cancer.
Oncologist
; 27(12): 1004-e926, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36124629
12.
TITE-BOIN12: A Bayesian phase I/II trial design to find the optimal biological dose with late-onset toxicity and efficacy.
Stat Med
; 41(11): 1918-1931, 2022 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35098585
13.
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa.
Gut
; 70(3): 555-566, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32641470
14.
Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.
Cancer
; 127(16): 2916-2925, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33873251
15.
CD73 expression defines immune, molecular, and clinicopathological subgroups of lung adenocarcinoma.
Cancer Immunol Immunother
; 70(7): 1965-1976, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416944
16.
Surgical Outcomes in Cancer Patients Undergoing Elective Surgery After Recovering from Mild-to-Moderate SARS-CoV-2 Infection.
Ann Surg Oncol
; 28(13): 8046-8053, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34176060
17.
IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves.
BMC Med Res Methodol
; 21(1): 111, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34074267
18.
The use of local and nonlocal priors in Bayesian test-based monitoring for single-arm phase II clinical trials.
Pharm Stat
; 20(6): 1183-1199, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34008317
19.
Incorporating historical information to improve phase I clinical trials.
Pharm Stat
; 20(6): 1017-1034, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33793044
20.
A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma.
Oncologist
; 25(10): e1457-e1463, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32608142